Gaeta’s last role was a brief stint at Shockwave, which named her CFO two months before accepting J&J’s $13.1 billion ...

The startup received de novo authorization for the AI tool, the first of its kind that analyzes mammogram images to predict ...

The latest fundraise included investors ARK Invest, Founders Fund, G42, Lightspeed, Sequoia Capital and others. Neuralink ...

Freenome plans to complete all modules of its premarket approval submission in mid-2025.

Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with ...

Smiths has not reported any serious injuries or deaths related to the issues, but the FDA sees a risk of harm.

The Trump Administration has effectively ended the Biden Administration's attempt to regulate lab-developed tests,” TD Cowen ...

Nvidia, which is already working with J&J and Medtronic, plans to partner with medtech companies to build platforms for ...

Boston Scientific’s $200 million tariff forecast assumed the 100%-plus tariffs on trade between the U.S. and China stayed in place and the paused tariffs on trade with Europe would resume in the third ...

Editor's note: This is the first story in a two-part series on the medtech IPO landscape. You can read the second story on how to take a company public here. When Ceribell went public in October, the ...

A federal court on Wednesday blocked many of President Donald Trump’s sweeping tariff executive orders, saying the president overstepped his use of emergency powers to enact them. The injunction came ...

Medical device maker Masimo said Tuesday that it does not expect a cyberattack it disclosed earlier this month to have a material effect on its fiscal 2025 revenue, nor does it expect the incident to ...